Comparison 10. Sublingual misoprostol plus injectable uterotonics versus injectable uterotonics.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Severe postpartum hemorrhage (>=1000 mL)	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	0.79 [0.46, 1.37]
1.1 200 mcg	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	0.79 [0.46, 1.37]
2 Blood transfusion	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	0.11 [0.01, 2.04]
2.1 200 mcg	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	0.11 [0.01, 2.04]
3 Any side effects	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	2.53 [1.58, 4.04]
3.1 200 mcg	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	2.53 [1.58, 4.04]
4 Vomiting	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	1.5 [0.70, 3.21]
4.1 200 mcg	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	1.5 [0.70, 3.21]
4.2 200 mcg	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Nausea	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	4.5 [0.99, 20.41]
5.1 200 mcg	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	4.5 [0.99, 20.41]
6 Headache	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	2.0 [0.37, 10.72]
6.1 200 mcg	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	2.0 [0.37, 10.72]
7 Shivering	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	4.33 [1.85, 10.16]
7.1 200 mcg	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	4.33 [1.85, 10.16]
8 Pyrexia (>= 38 C)	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	7.0 [0.87, 56.06]
8.1 200 mcg	1	250	Risk Ratio (M‐H, Fixed, 95% CI)	7.0 [0.87, 56.06]